Results 181 to 190 of about 939,495 (280)
Diagnostic Cytopathology, Volume 54, Issue 11, Page 805-811, November 2026.ABSTRACT Background The emergence of personalized therapy and molecular sequencing has significantly transformed the management of advanced non–small cell lung carcinoma (NSCLC). Supernatants obtained from fine needle aspiration (FNA) have been shown to be a reliable source of high‐quality nucleic acid for molecular testing.
Adeyinka Akinsanya +9 more
wiley +1 more source
Neoadjuvant Selpercatinib for Stage IIIA Primary Pulmonary Adenocarcinoma With RET Fusion: A Case Report. [PDF]
Respirol Case RepCui Z, Hu Y, Zhao J, Mu C, Li C.
europepmc +1 more source
The Role of Variance Risk Premium in Derivative Pricing: Modeling, Estimation and Impact
Journal of Futures Markets, Volume 46, Issue 11, Page 1811-1823, November 2026.ABSTRACT This paper estimates a model where variance risk premiums (VRP) is not fully explained by equity risk premiums (ERP). This separation can be detected thanks to a new breed of GARCH models with enough innovations to disconnect returns from variances. This type of risk‐neutralization is compatible with continuous‐time settings.
Marcos Escobar‐Anel +2 more
wiley +1 more source
Lifetime Estimation of Blade Erosion Using Rain Erosion Test Data With Different Analysis Methods
Wind Energy, Volume 29, Issue 11, November 2026.ABSTRACT Lifetime estimation regarding leading‐edge erosion of wind turbine blades involves a series of mathematical and statistical procedures, including regression fitting, tolerance interval formulation, and weathering modeling approaches. This work investigates the intermediate steps in the fatigue assessment process and the associated sources of ...
J. E. Simon +4 more
wiley +1 more source
Safety and effectiveness of selpercatinib in patients with RET fusion-positive non-small cell lung cancer in real-world clinical practice: a postmarketing study in Japan. [PDF]
Jpn J Clin OncolChen Y +3 more
europepmc +1 more source